MedTrace Logo

Effectiveness of Aspirin in Compare With Heparin Plus Aspirin in Recurrent Pregnancy Loss Treatment

NCT01542411 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 520

Last updated 2012-03-02

No results posted yet for this study

Summary

This study evaluated the effect of anticoagulant treatment on the live-birth rate in women with a history of at least two continuous unexplained miscarriages or thrombophilia. It also compared two methods of treatment with aspirin and aspirin plus heparin.

Conditions

  • Recurrent Pregnancy Loss

Sponsors & Collaborators

  • Yazd Medical University

    lead OTHER

Principal Investigators

  • Tahere Jahaninejad, MSC · Yazd Shahid Sadoughi Medical Sciences University and Health Services, Yazd, Iran

Eligibility

Min Age
19 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-04-30

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01542411 on ClinicalTrials.gov